title: Prime pick: Researchers get selective about T cells for cancer therapy.
authors.affiliation: Nature Medicine's assistant news editor, based in Cambridge, Massachusetts.
authors.forename: Shraddha
authors.initials: S
authors.lastname: Chakradhar
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D060846:Cell Engineering / Q000639:trends*; D064987:Cell- and Tissue-Based Therapy / Q000639:trends*; D006801:Humans; D014411:Neoplastic Stem Cells / Q000276:immunology / Q000637:transplantation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D011948:Receptors, Antigen, T-Cell